Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Yosuke Sugiyama"'
Autor:
Shuzo Hamamoto, Yoshihiko Tasaki, Shimpei Yamashita, Junya Furukawa, Kazutoshi Fujita, Ryotaro Tomida, Makito Miyake, Noriyuki Ito, Hideto Iwamoto, Yosuke Sugiyama, Kazumi Taguchi, Takahiro Yasui
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionPretreatment hemoglobin and neutrophil levels were previously reported to be important indicators for predicting the effectiveness of ipilimumab plus nivolumab (IPI + NIVO) therapy for renal cell carcinoma (RCC). Therefore, we aimed to va
Externí odkaz:
https://doaj.org/article/5b6b73ff1f2c463c9bc8d66119b8900c
Autor:
Keitaro Iida, Taku Naiki, Toshiki Etani, Takashi Nagai, Yosuke Sugiyama, Teruki Isobe, Maria Aoki, Satoshi Nozaki, Yusuke Noda, Nobuhiko Shimizu, Nami Tomiyama, Masakazu Gonda, Hiroyuki Kamiya, Hiroki Kubota, Akihiro Nakane, Ryosuke Ando, Noriyasu Kawai, Takahiro Yasui
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract We elucidated the efficacy of gut microbiome–altering drugs on pembrolizumab efficacy in patients with metastatic urothelial carcinoma (mUC). Clinical data were analyzed retrospectively from 133 patients with mUC who received second-line p
Externí odkaz:
https://doaj.org/article/636a77532568474d8e2fe2141e86e63e
Autor:
Yoshihiko Tasaki, Yosuke Sugiyama, Shuzo Hamamoto, Taku Naiki, Takehiro Uemura, Keisuke Yokota, Daisuke Kawakita, Motoki Nakamura, Ryo Ogawa, Takaya Shimura, Yoshihisa Mimura, Yuji Hotta, Kunihiro Odagiri, Nanami Ito, Moeko Iida, Yuka Kimura, Hirokazu Komatsu, Hiromi Kataoka, Shuji Takiguchi, Akimichi Morita, Shinichi Iwasaki, Katsuhiro Okuda, Akio Niimi, Takahiro Yasui, Yoko Furukawa‐Hibi
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 21666-21679 (2023)
Abstract Background Immune checkpoint inhibitors (ICIs) can cause severe immune‐related adverse events (irAEs). However, biomarkers for irAEs common to different types of ICIs and cancers have not been reported. This study examined whether eosinoph
Externí odkaz:
https://doaj.org/article/3dca76b8d62144b8b8abb776104bc87c
Autor:
Shuzo Hamamoto, Yoshihiko Tasaki, Toshiharu Morikawa, Taku Naiki, Toshiki Etani, Kazumi Taguchi, Shoichiro Iwatsuki, Rei Unno, Tomoki Takeda, Takashi Nagai, Kengo Kawase, Yoshihisa Mimura, Yosuke Sugiyama, Atsushi Okada, Yoko Furukawa-Hibi, Takahiro Yasui
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 12, p 3365 (2024)
Background/Objectives: Immuno-oncology plus tyrosine kinase inhibitor (IO+TKI) combination therapy is an essential first-line therapy for advanced renal cell carcinoma (RCC). However, reports of its efficacy and safety as late-line therapy are lackin
Externí odkaz:
https://doaj.org/article/e6236290fa4e44f8ab65272f8eaa47cc
Autor:
Toshiharu Morikawa, Taku Naiki, Yosuke Sugiyama, Aya Naiki-Ito, Takashi Nagai, Toshiki Etani, Keitaro Iida, Teruki Isobe, Yusuke Noda, Nobuhiko Shimizu, Maria Aoki, Masakazu Gonda, Rika Banno, Hiroki Kubota, Ryosuke Ando, Yukihiro Umemoto, Noriyasu Kawai, Takahiro Yasui
Publikováno v:
Cancers, Vol 16, Iss 9, p 1725 (2024)
Background: In the EV-301 trial, enfortumab vedotin prolonged survival in patients with locally advanced or metastatic urothelial carcinoma previously treated with platinum-based therapy and programmed cell death 1/programmed death-ligand 1 inhibitor
Externí odkaz:
https://doaj.org/article/7fbb5beead144886ab775b7c3e531565
Autor:
Taku Naiki, Aya Naiki‐Ito, Tatsuya Kawai, Hirokazu Komatsu, Ryutaro Nishikawa, Masakazu Gonda, Maria Aoki, Yosuke Sugiyama, Yoshihiko Tasaki, Takahiro Yasui
Publikováno v:
IJU Case Reports, Vol 5, Iss 6, Pp 431-435 (2022)
Introduction Treatment‐emergent small cell/neuroendocrine prostate cancer occurs predominantly in advanced or metastatic castration‐resistant prostate cancer that arises when prostate adenocarcinoma is transformed after androgen deprivation thera
Externí odkaz:
https://doaj.org/article/29643416f7f84b1681fb43dbc80196d3
Autor:
Nami Tomiyama, Taku Naiki, Aya Naiki‐Ito, Tatsuya Kawai, Toshiki Etani, Masakazu Gonda, Maria Aoki, Toshiharu Morikawa, Yosuke Sugiyama, Takahiro Yasui
Publikováno v:
IJU Case Reports, Vol 5, Iss 6, Pp 474-478 (2022)
Introduction The prognosis of adrenal metastasis from non‐small cell lung cancer is very poor. A recent report described the efficacy of the surgical removal of adrenal metastasis when solitary. However, metachronous bilateral adrenal metastasis is
Externí odkaz:
https://doaj.org/article/8b6b1ba295d148a0aba3b96a1cb39837
Autor:
Taku Naiki, Kiyoshi Takahara, Hiromitsu Watanabe, Keita Nakane, Yosuke Sugiyama, Takuya Koie, Ryoichi Shiroki, Hideaki Miyake, Takahiro Yasui
Publikováno v:
Cancers, Vol 15, Iss 22, p 5333 (2023)
Malnutrition is associated with prognosis in cancer. The geriatric nutritional risk index (GNRI), based on the ratio of actual to ideal body weight and also serum albumin level, is a simple screening tool for assessing nutrition. We investigated the
Externí odkaz:
https://doaj.org/article/7246e14dc11e42b9ab6fd2826df2a586
Autor:
Nayuka Matsuyama, Taku Naiki, Shuzo Hamamoto, Yosuke Sugiyama, Yasue Kubota, Takashi Hamakawa, Toshiki Etani, Shoichiro Iwatsuki, Kazumi Taguchi, Yuya Ota, Masakazu Gonda, Maria Aoki, Toshiharu Morikawa, Taiki Kato, Atsushi Okada, Takahiro Yasui
Publikováno v:
Diagnostics, Vol 13, Iss 20, p 3173 (2023)
Background: The aim was to investigate the incidence and clinical predictive factors of de novo overactive bladder (OAB) after robot-assisted radical prostatectomy (RARP), including a Retzius-sparing (RS) approach, in the same period at a single inst
Externí odkaz:
https://doaj.org/article/26af7ff8e6da4c7eb8bb416591e59340
Autor:
Yoshihisa Mimura, Yosuke Sugiyama, Taku Naiki, Tomoya Kataoka, Yoshihiko Tasaki, Toshiki Etani, Nami Tomiyama, Nayuka Matsuyama, Kunihiro Odagiri, Kazunori Kimura, Takahiro Yasui
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 7, Iss , Pp 100179- (2022)
Background: The number of patients with cancer and end-stage renal disease is increasing because of the success of hemodialysis treatment. However, methods for monitoring opioids to control severe pain induced by cancer remain unsatisfactory. Case Pr
Externí odkaz:
https://doaj.org/article/966b9fcc12c74a27818894f938bba383